Status:

WITHDRAWN

The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus

Lead Sponsor:

Augusta University

Conditions:

Status Asthmaticus

Eligibility:

All Genders

2-18 years

Phase:

PHASE3

Brief Summary

The purpose of this investigation is to perform a pilot study assessing the safety and utility of intravenous ketamine as an adjuvant therapy in the emergency department setting for pediatric patients...

Detailed Description

This is a pilot study of a cohort of 20 subjects to assess the feasibility, safety and efficacy of ketamine in status asthmaticus. The study will take place at the Augusta University's pediatric emer...

Eligibility Criteria

Inclusion

  • Pediatric patients (≥2 years and ≤ 18 years old)
  • Patients presenting in status asthmaticus:
  • Patients with a CAS of greater than or equal to 10 on presentation that have received at least two (appropriately dosed based on weight) albuterol treatments prior to arrival
  • OR
  • Patients with a CAS of greater than or equal to 10 that have not received treatment prior to arrival and after 1 hour of treatment per the severe asthma pathway do not have a decrease in CAS of greater than 2
  • OR
  • Patients with a CAS above 6 but less than 10 as measured 1 hour after initiation of standard treatment per AU's moderate asthma pathway

Exclusion

  • Pregnancy
  • Congestive Heart Failure or prior diagnosis of cardiovascular disease (congenital or acquired)
  • Chronic lung disease outside of a previous diagnosis of Asthma
  • Seizure disorder
  • Liver disease
  • History of hypertension greater than 95% for age
  • Obstructive Sleep Apnea with AHI greater than 5
  • History of allergic or serious reaction to Ketamine
  • Significant history of psychiatric illness defined as any patient with a diagnosis of psychiatric illness meeting the Diagnostic and Statistical Manual of Mental Disorders V criteria (severe Autism)

Key Trial Info

Start Date :

January 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03338205

Start Date

January 1 2020

End Date

January 1 2022

Last Update

February 6 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.